Guerbet stock falls after H1 profit margin erosion

Guerbet's stock declined 8% after its H1 2025 results confirmed a previously issued profit warning, revealing a significant deterioration in its restated EBITDA margin to 12.9% from 15.4% due to weak operating leverage and sustained pricing pressure. Net income fell sharply to €1.3 million from €7.7 million, and while free cash flow improved to -€8.4 million, it remained negative. The company reiterated its downgraded guidance for the remainder of the year, signaling that recovery expectations have been pushed further out and indicating continued operational challenges.

Analysis

Guerbet's H1 2025 results have confirmed a previously issued profit warning, triggering an 8% decline in its stock and revealing significant operational stress. The core issue is a sharp deterioration in profitability, with the restated EBITDA margin contracting to 12.9% from 15.4% year-over-year, driven by weak operating leverage and sustained pricing pressure. This margin compression severely impacted the bottom line, causing net income to collapse to €1.3 million from €7.7 million in the prior-year period. While free cash flow improved to -€8.4 million from -€29.1 million, it remains negative, limiting financial flexibility; notably, this improvement stemmed from working capital management rather than a recovery in core operational cash generation. With net debt at €353 million, the company's reiterated downgraded guidance for the remainder of the year signals that these fundamental challenges are expected to persist and that a recovery has been pushed further into the future.

Key Decisions for Investors

• Given the confirmed profit warning, severe margin compression, and reiterated downgraded guidance, a highly cautious stance on Guerbet is warranted as operational headwinds are expected to persist.
• Investors should closely monitor future reports for any stabilization in EBITDA margins and a return to positive free cash flow from operations, as the recent improvement was driven by non-recurring working capital changes.
• Considering the lack of a near-term catalyst and the persistent pricing pressures, existing shareholders might consider reducing their positions, while prospective investors should likely remain on the sidelines pending evidence of a fundamental turnaround.